Category - Executive Moves

Executive Moves

Lucid appoints policy leader Danielle Scelfo as SVP, Market Access & Gov’t Affairs

Lucid Diagnostics (NASDAQ: LUCD) announced the appointment of Danielle Scelfo as SVP, Market Access & Government Affairs, reporting to the CEO. With more than 25 years of strategic and operational experience across...

September 16, 2025

Executive Moves

ALX appoints Dr. Barbara Klencke as interim CMO

ALX Oncology Holdings (NASDAQ: ALXO) has announced the appointment of board member Barbara Klencke, MD, as interim chief medical officer, (CMO). According to ALX, Dr. Alan Sandler is departing from the role of CMO and...

September 12, 2025

Executive Moves

MedX appoints Dr. Paul Matts as strategic advisor

MedX Health (TSXV: MDX) has announced the appointment of Dr. Paul J. Matts, internationally recognized skin scientist, biochemist, and educator, as strategic advisor. Dr. Matts is an academic and industry leader, as...

September 9, 2025

Executive Moves

Tatjana Mitchell joins Evolus as CFO

Evolus (NASDAQ: EOLS) has announced the appointment of Tatjana Mitchell as chief financial officer (CFO), effective today. Ms. Mitchell brings more than 20 years of strategic and operational finance leadership across...

September 8, 2025

Executive Moves

Dr. Thomas J. Errico elected electroCore’s chairman of the board; Peter Cuneo retires

electroCore (NASDAQ: ECOR) has announced the election of Thomas J. Errico, MD, as chairman of the board and the departure of Peter Cuneo from its board of directors (BOD). According to electroCore, Mr. Cuneo will...

September 5, 2025

Executive Moves

Adagene appoints Dr. Axel Hoos as executive advisor

Adagene (NASDAQ: ADAG) has announced the appointment of immuno-oncology pioneer, Axel Hoos, MD, PhD, as executive advisor. Most recently, Dr. Hoos served as CEO of Scorpion Therapeutics, which was acquired by Eli Lilly...

September 3, 2025

Executive Moves

Dr. Barbara Krebs-Pohl joins CASI’s BOD

CASI Pharmaceuticals (NASDAQ: CASI) has announced the appointment of Barbara Krebs-Pohl, PhD, as an independent director to its board of directors (BOD). Dr. Krebs-Pohl brings more than 27 years of leadership experience...

September 2, 2025

Executive Moves

Renowned surgical oncologist, Dr. Ted James, joins Perimeter as CMO

Perimeter Medical Imaging AI (TSX-V: PINK; OTCQX: PYNKF) has announced the appointment of Ted James, MD, MHCM, FACS, to the newly created position of chief medical officer (CMO). In this fractional role, Dr...

August 28, 2025

Executive Moves

Dr. Ramón Polo joins Aligos as SVP, head of global and regulatory affairs

Aligos Therapeutics (NASDAQ: ALGS) has announced the appointment of Ramón Polo, PharmD, PhD, MBA as senior vice president, head of global regulatory affairs, effective immediately. Dr. Polo’s extensive background...

August 21, 2025

Executive Moves

Alto appoints Dr. Raymond Sanchez to BOD

Alto Neuroscience (NYSE: ANRO) has announced the appointment of industry veteran Raymond Sanchez, MD, to its board of directors (BOD), effective August 12, 2025. Dr. Sanchez brings extensive experience in medicine and...

August 13, 2025

Category - Executive Moves

Subscribe